PortfoliosLab logo

ProShares Ultra Nasdaq Biotechnology (BIB)

ETF · Currency in USD · Last updated Mar 26, 2023

BIB is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (200%). BIB launched on Apr 7, 2010 and has a 0.95% expense ratio.

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in ProShares Ultra Nasdaq Biotechnology in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $69,051 for a total return of roughly 590.51%. All prices are adjusted for splits and dividends.

BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIB


ProShares Ultra Nasdaq Biotechnology had a return of -10.29% year-to-date (YTD) and -14.49% in the last 12 months. Over the past 10 years, ProShares Ultra Nasdaq Biotechnology had an annualized return of 10.84%, outperforming the S&P 500 benchmark which had an annualized return of 9.86%.

1 month-6.91%-0.66%
6 months9.54%5.67%
1 year-14.49%-10.89%
5 years (annualized)-0.69%8.95%
10 years (annualized)10.84%9.86%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ProShares Ultra Nasdaq Biotechnology Sharpe ratio is -0.27. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)

Dividend History

ProShares Ultra Nasdaq Biotechnology granted a 0.04% dividend yield in the last twelve months. The annual payout for that period amounted to $0.02 per share.


Dividend yield


Monthly Dividends

The table displays the monthly dividend distributions for ProShares Ultra Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the ProShares Ultra Nasdaq Biotechnology. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ProShares Ultra Nasdaq Biotechnology is 67.24%, recorded on Jun 27, 2016. It took 1152 trading sessions for the portfolio to recover.



To Bottom


To Recover



-67.24%Jul 21, 2015237Jun 27, 20161152Jan 25, 20211389
-64.76%Feb 9, 2021339Jun 13, 2022
-41.45%May 13, 201160Aug 8, 2011112Jan 18, 2012172
-39.01%Feb 26, 201433Apr 11, 2014114Sep 24, 2014147
-36.3%Apr 16, 201048Jul 1, 201093Dec 17, 2010141
-24.73%Oct 8, 201227Nov 15, 201271Mar 1, 201398
-20.33%May 15, 201326Jun 20, 201314Jul 11, 201340
-17.74%Mar 23, 201528Apr 30, 201534Jun 18, 201562
-17.57%Oct 2, 20136Oct 9, 201332Nov 22, 201338
-16.83%Sep 25, 201414Oct 14, 20147Oct 23, 201421

Volatility Chart

Current ProShares Ultra Nasdaq Biotechnology volatility is 40.07%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BIB (ProShares Ultra Nasdaq Biotechnology)
Benchmark (^GSPC)